Dianthus Therapeutics, Inc. DNTH
90.00 USD +3.97 (+4.61%)
At closeNov 9, 2026, 4:00 PM EST
90.00 0.00 0.00%
After hours · Nov 9, 4:00 PM ET
84.41 Day range 91.82
34.29 52-week range 117.88
- YTD
- +118.39%
- 1 year
- +148.07%
DNTH revenue history
Revenue is income from the company’s ordinary business activities.
2,036,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 2,036,000 | -4,199,000 | -67.35% |
| FY 2024 | 2024-12-31 | 6,235,000 | 3,409,000 | 120.63% |
| FY 2023 | 2023-12-31 | 2,826,000 | -3,591,000 | -55.96% |
| FY 2022 | 2022-12-31 | 6,417,000 | 6,417,000 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:02:18.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.